FindTrial
Sign In

Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study

Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032770
Enrollment
Unknown
Registered
2020-05-10
Start date
2020-01-29
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

asymptomatic versus mild and moderate confirmed COVID-19 patients:Nil

Sponsors

Department of Science and Technology of Guizhou Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 80 Years

Inclusion criteria

Inclusion criteria: All asymptomatic and confirmed patients with COVID-19 in Guizhou Provincial Staff Hospital.

Exclusion criteria

Exclusion criteria: Non-COVID-19 infections.

Design outcomes

Primary

MeasureTime frame
Treatment cycle;—

Countries

China

Contacts

Public ContactWei Zhang

Affiliated Hospital of Zunyi Medical University

zhangwei_hxicu@163.com+86 18982262419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026